A Feasibility Study to Collect Data in Patients With Haemophilia

AstraZeneca

Status: Completed

Conditions: Hemophilia

Treatments: Other: Laboratory variables

Study type: Observational

Funder types: Industry

Identifiers

NCT00798499

D0960M00006

Details and patient eligibility

About

The purpose of this study is to collect reference data in patients with haemophilia. The study will also collect and store blood samples for potential future exploratory research in the disease area.

Enrollment: 50 estimated patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Provision of written informed consent
• Patients with haemophilia, all severities
• At least 18 years old.

Exclusion criteria

• No exclusion criteria

Trial design

50 participants in 1 patient group

1

Description:

Laboratory variables

Treatment:

Other: Laboratory variables